Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells. - Wikidata - wikimedia - TriplyDB

Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells.

Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells.

http://www.wikidata.org/entity/Q42969190

about

Evolving Insights on Metabolism, Autophagy, and Epigenetics in Liver Myofibroblasts Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step Extracellular matrix and liver disease Molecular mechanism and treatment of viral hepatitis-related liver fibrosis.Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomes Statin Use and Risk of Cirrhosis and Related Complications in Patients with Chronic Liver Diseases: a Systematic Review and Meta-analysis.Future therapy of portal hypertension in liver cirrhosis - a guess.Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions.Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis The crucial role of cholangiocytes in cholangiopathies Novel Rat Model of Repetitive Portal Venous Embolization Mimicking Human Non-Cirrhotic Idiopathic Portal Hypertension.Interplay of Matrix Stiffness and c-SRC in Hepatic Fibrosis.Atorvastatin and rosuvastatin do not prevent thioacetamide induced liver cirrhosis in rats Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES.Statins Increase Mitochondrial and Peroxisomal Fatty Acid Oxidation in the Liver and Prevent Non-Alcoholic Steatohepatitis in Mice.Experimental liver fibrosis research: update on animal models, legal issues and translational aspects.Therapeutic targets in liver fibrosis.Role of integrins in fibrosing liver diseases.Future treatments of cirrhosis.New cellular and molecular targets for the treatment of portal hypertension.A morphological and immunohistochemical study of the effects of prednisolone or ursodeoxycholic acid on liver histology in feline lymphocytic cholangitis.The different expressed serum proteins in rhCygb treated rat model of liver fibrosis by the optimized two-dimensional gel electrophoresis.Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments.Use of Statins in Patients with Chronic Liver Disease and Cirrhosis: Current Views and Prospects.Novel treatment options for portal hypertension.Advances in the treatment of portal hypertension in cirrhosis.Statin pretreatment inhibits the lipopolysaccharide-induced epithelial-mesenchymal transition via the downregulation of toll-like receptor 4 and nuclear factor-κB in human biliary epithelial cells.Sinusoidal communication in liver fibrosis and regeneration.Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension.How to Face Chronic Liver Disease: The Sinusoidal Perspective.Rationale for the use of statins in liver disease.Novelties in the pathophysiology and management of portal hypertension: new treatments on the horizon.The calcium-activated potassium channel KCa3.1 is an important modulator of hepatic injury.Statins Modulate Cyclooxygenase-2 and Microsomal Prostaglandin E Synthase-1 in Human Hepatic Myofibroblasts.Antifibrotic effect of AT-1 blocker and statin in rats with hepatic fibrosis.Plumbagin Ameliorates CCl 4 -Induced Hepatic Fibrosis in Rats via the Epidermal Growth Factor Receptor Signaling Pathway.Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis.FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis Effects and mechanism of adenovirus-mediated phosphatase and tension homologue deleted on chromosome ten gene on collagen deposition in rat liver fibrosis

P2860

Q26745566-E96D9CC8-F823-4542-BF8A-91214DD21C2D Q26771518-088D616C-BE12-4D90-8595-D669D7E931B3 Q26823060-F38921B2-7852-4A45-8A69-2AB74D84128E Q27692609-D796E655-397E-444B-8D58-CEB756A4C4A9 Q28081216-2782E242-B7C8-4906-8E67-39183C6C80FE Q30234533-46EE86CC-8A59-4BAE-9E48-11B41A79F165 Q34446521-AF94CA9D-FEEC-4AEF-960F-8B6696713F6A Q34747195-DA2401A5-9208-469F-8489-A9FCFB96576C Q35136411-8CEE85A4-294C-4FA3-A635-FDF91B8048F2 Q35787734-0F903BA5-A9A2-4D4E-A95F-CF5472A023C2 Q36113261-AF1F443C-7557-4F02-A528-55FE7FCDBF5E Q36121721-66BA5A8C-B768-4522-85A9-CC203246BB11 Q36339714-195F3180-4542-4068-B236-455EFFF9A8F8 Q36541169-57450340-D376-4E41-87FA-52A6C87FBD0E Q37029796-F52DF0CA-7F44-49BD-AD4A-993076413306 Q37348597-371AAED7-CF6A-401C-A790-92FA12C68502 Q37363773-74F8A030-0468-4079-8E39-0C2D1F3B6009 Q37828321-F0C73352-C6C6-4445-83BC-87146CDFEDCC Q37887339-E6F3EB9D-97D2-47F4-AEB3-AAAEB53ED892 Q38218607-2D74074D-AF16-45B8-9775-866DF44922A7 Q38383418-7EDE052A-FF2A-4CB3-AB66-1D266359FBFA Q38393029-D2F9AD3B-9EDD-4701-8913-82CF5FA89919 Q38431856-9DAA77D7-67D2-49E5-B1E0-B04CD885BB39 Q38446357-2ED5B4E4-DEB4-4A4A-BB3E-2314CCE08CC7 Q38656007-5D4939AB-5BDF-40D6-A701-C4C254FD6A3A Q38680437-A32BFCDA-655B-4821-B218-A838F975ED2A Q38776991-16E20402-38C1-485B-B5F1-6B0F321CE865 Q38819131-0B211F0C-3B1F-4838-B776-690901C89774 Q38827092-DC283BBD-EBF6-427B-9E9F-9F065685B584 Q38831994-5D7DEB7B-DAA0-4066-AB99-911B90D8D1D0 Q38940706-C4CA2433-E7AB-4CF4-98BF-A518552D00D1 Q39171942-87BB9B55-1C2B-4351-B3CE-B0D86B785BB6 Q39429850-0E5AC533-9788-44DC-9ADF-B0DD92EE36C9 Q39647330-D170B86F-13F6-4C2A-8409-C30804DF7D4C Q40419037-AD1AB179-1A18-4DF1-A62B-F9A2942C726C Q40736144-3ECF7721-CF91-4353-953E-1170D1037B84 Q40917613-405FEF4C-36CA-4E3A-8CCC-065FF0C59B21 Q41029212-30A748B8-FBD4-41CF-8A25-477F312F655B Q41107620-770FF3CA-06E8-4E88-AD22-C1658ADD8FBA Q41608495-F8C3A788-5557-47BC-9E16-A2ED219B37FF

P2860

Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells.

http://www.wikidata.org/entity/Q42969190

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Atorvastatin attenuates hepati ...... ver of hepatic stellate cells.

@en

Atorvastatin attenuates hepati ...... ver of hepatic stellate cells.

@nl

type

label

Atorvastatin attenuates hepati ...... ver of hepatic stellate cells.

@en

Atorvastatin attenuates hepati ...... ver of hepatic stellate cells.

@nl

prefLabel

Atorvastatin attenuates hepati ...... ver of hepatic stellate cells.

@en

Atorvastatin attenuates hepati ...... ver of hepatic stellate cells.

@nl

P1433

Q42969190-018EE6E0-16F7-4651-9E76-9531E8637828

P1476

Q42969190-284AC694-2216-4CFB-AB05-B4C35E1D1777

P2093

Q42969190-1B876CE3-9CE7-45BD-A8ED-0B81BB5533EF

Q42969190-1C91E76D-19BE-4E25-B359-FD963A22A749

Q42969190-2D77048E-0171-4017-B322-50C6FD8733FD

Q42969190-4387294A-923E-42A3-AEBA-40023812DA4B

Q42969190-63C2FEEB-9502-4C99-AB76-575729AF5B0C

Q42969190-9471CD0E-D972-4D90-BAF7-CAF3EAAD024C

Q42969190-B1428FC2-CD3B-47A1-8E8C-EAE58E191A59

Q42969190-B7E24893-0C1C-46FC-AF38-4EB567D0000E

Q42969190-C80CC52E-2FF5-41D0-A970-A24369E7EEEB

Q42969190-F1882CFF-CE35-448C-A0B6-A7D6D185265F

P304

Q42969190-593F6939-76C5-486E-AE62-0FEB237074CC

P31

Q42969190-1EFC9954-554F-444B-AD20-7250479EA71A

P356

Q42969190-73A0637B-5A31-4792-B7FA-037A81E69BB7

P433

Q42969190-6BADF057-4044-41CC-A93E-B3968D26A8E0

P478

Q42969190-AAE27790-45F8-43E7-98CD-A16D1E6D24ED

P50

Q42969190-42D15651-4ED7-4CED-97CE-4EFBA19033D1

P577

Q42969190-72C00794-2990-469B-A724-4424D30A091C

P5875

Q42969190-C27AC3BC-946E-4641-9843-B366B80E80A0

P698

Q42969190-438D4034-700B-42E7-B691-432F20E752A2

P356

J.JHEP.2010.04.025

P1433

Journal of Hepatology

P1476

Atorvastatin attenuates hepati ...... ver of hepatic stellate cells.

@en

P2093

Annabelle Vogt

http://www.w3.org/2001/XMLSchema#string

Frank Lammert

http://www.w3.org/2001/XMLSchema#string

Hans-Peter Dienes

http://www.w3.org/2001/XMLSchema#string

Jörg Heller

http://www.w3.org/2001/XMLSchema#string

Jürg Reichen

http://www.w3.org/2001/XMLSchema#string

Khanwali Shir

http://www.w3.org/2001/XMLSchema#string

Margarete Odenthal

http://www.w3.org/2001/XMLSchema#string

Martin Hennenberg

http://www.w3.org/2001/XMLSchema#string

Michaela Granzow

http://www.w3.org/2001/XMLSchema#string

Sabine Klein

http://www.w3.org/2001/XMLSchema#string

P304

702-712

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JHEP.2010.04.025

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45199522

http://www.w3.org/2001/XMLSchema#string

P698

20633948

http://www.w3.org/2001/XMLSchema#string